United States· US:74157-012_2cda4c71-2cf3-26b6-e063-6294a90a8530
Halcinonide Topical Solution
A halcinonide product containing halcinonide, registered in United States by INA Pharmaceutics Inc. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Halcinonide is registered in 3 of 19 countries.
Countries holding a registration under ATC D07AD02 (halcinonide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Halcinonide · ATC D07AD02
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HALCINONIDE
- Manufacturer
- INA Pharmaceutics Inc
- Country
- United States (US)
- ATC code
- D07AD02
- ATC class
- Halcinonide
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1174157012121 BOTTLE, PLASTIC in 1 CARTON (74157-012-12) / 120 mL in 1 BOTTLE, PLASTIC
- ndc1174157-012-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for halcinonide.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Halcinonide · interactions on record
55 records
Same medicine, other countries
Halcinonide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHalciderm Topical 0.1% creamBristol-Myers Squibb Pharmaceuticals Ltd
- ItalyHALCIDERM*crema derm 30 g 0,1%TEOFARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Italy · Halciderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad4c0e88-f061-415e-ac37-e9cd5155cc2f GET /v1/drugs/ad4c0e88-f061-415e-ac37-e9cd5155cc2f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1",
"substance": "HALCINONIDE",
"productndc": "74157-012",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA217671",
"marketing_category": "ANDA"
}See everything about halcinonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.